The findings from the current study combined with our previous observations demonstrate that BRB inhibits tumor development in rat esophagus, at least in part, through the reversal of oxidative stress and suppression of NFκB/MAPK activation, in parallel to the inhibition of inflammation. Here, NFKB1 is linked to neoplasm.